Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 905-908-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-12-05 to 2013-05-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study comparable to OECD TG 487 (2010)
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD TG 487 (2010)
- Deviations:
- yes
- Remarks:
- see below
- Principles of method if other than guideline:
- A series of in-house non-GLP validation experiments was performed to get proper responses of statistical significance when using the specified positive controls. To achieve such response the test design, specifically for the treatment, the expression phase and harvest time, was slightly modified compared to the OECD Guideline 487. The optimum in responses was found with the following schedule, which was decided to be used in the main study:Experiment I: 4 hours pulse treatment (with and without metabolic activation), expression phase 16 hours, cytokinesis block 20 hours.Experiment II: 4 hours pulse treatment (with metabolic activation), expression phase 16 hours, cytokinesis block 20 hours. 20 hours continuous treatment (without metabolic activation), cytokinesis block 20 hours.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Reaction mass of CXN1-55
- IUPAC Name:
- Reaction mass of CXN1-55
- Details on test material:
- - Name of test material (as cited in study report): Reaction mass of CXN1-55- Substance type: multi-constituent substance- Physical state: Paste- Stability under test conditions: substance considered stable under normal ambient conditions- Storage condition of test material: at room temperature at 20 ± 5 °C, in the dark.
Constituent 1
Method
- Target gene:
- The occurrence of micronuclei in interphase blood lymphocytes provides an indirect but easy and rapid measure of chromosomal damage and aneugenicity.
Species / strain
- Species / strain / cell type:
- lymphocytes: blood samples
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Blood samples were obtained from healthy, non-smoking donors not receiving medication. For this study, blood was collected from a female donor (24 years old) for Experiment I and from a female donor (34 years old) for Experiment II. All donors had a previously established low incidence of micronuclei in their peripheral blood lymphocytes. Blood samples were drawn by venous puncture and collected in heparinized tubes by Dr. V. Theodor (64380 Rossdorf, Germany). The tubes were sent to Harlan CCR to initiate cell cultures within 24 hrs after blood collection. The blood was stored before use at 4 °C.- Properly maintained: yes
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver S9 obtained from phenobarbital/beta-naphthoflavone induced rats were used as the metabolic activation system.
- Test concentrations with justification for top dose:
- Experiment I: 32.5, 56.8, 99.5, 174.1, 304.6, 533.1, 932.9, 1632.7, 2857.1, 5000.0 µg/mLExperiment II: 1632.7, 2857.1, 5000.0 µg/mL
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water- Justification for choice of solvent/vehicle: test item soluble in water
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: About 48 hours after seeding 2 blood cultures (10 mL each) were set up in parallel in 25 cm² cell culture flasks for each test group.DURATION- Preincubation period: approx. 48 hours- Exposure duration: 4 hours or 20 hours- Expression time (cells in growth medium)/Fixation time (start of exposure up to fixation or harvest of cells):4 hours of exposure + 16 hours of recovery + 20 hours with Cytochalasin B (4 µg/mL)20 hours of exposure + 20 hours with Cytochalasin B (4 µg/mL)SPINDLE INHIBITOR (cytogenetic assays): Cytochalasin B (4 µg/mL)STAIN (for cytogenetic assays): Giemsa (MERCK, 64293 Darmstadt, Germany)NUMBER OF REPLICATIONS: 2 per treatment and per sampling dateNUMBER OF CELLS EVALUATED: 1000 binucleate cells per culture were scored for cytogenetic damage on coded slides.DETERMINATION OF CYTOTOXICITY- Method: Cytokinesis-block proliferation index
- Evaluation criteria:
- A test item can be classified as non-mutagenic if:1. the number of micronucleated cells in all evaluated dose groups is in the range of the laboratory historical control data and/or2. no statistically significant or concentration-related increase in the number of micronucleated cells is observed.A test item can be classified as mutagenic if:1. the number of micronucleated cells is not in the range of the historical laboratory control data and2. either a concentration-related increase of micronucleated cells in three test groups or a statistically significant increase of the number of micronucleated cells is observed.
- Statistics:
- Statistical significance was confirmed by means of the Chi square test. However, both biological and statistical significance should be considered together. If the criteria for the test item mentioned above are not clearly met, the classification with regard to the historical data and the biological relevance is discussed and/or a confirmatory experiment is performed.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS- Effects of pH: noExp. I:Solvent control 7.65000 mg/L 7.6Exp. II:Solvent control 7.65000 mg/L 7.6- Effects of osmolality: noExp. I:Solvent control 282 mOsm5000 mg/L 355 mOsm/L2857.1 mg/L 329 mg/L1632.7 mOsm/LExp. II:Solvent control 283 mOsm5000 mg/L 355 mOsm/L2857.1 mg/L 326 mg/L- Evaporation from medium: not relevant- Water solubility: soluble up to and including 5 mg/mL- Precipitation: not observed- Other confounding effects:noRANGE-FINDING/SCREENING STUDIES:A preliminary cytotoxicity test was performed to determine the concentrations to be used in the main experiment. Cytotoxicity is characterized by the percentages of reduction in the CBPI in comparison with the controls (% cytostasis) by counting 500 cells per culture in duplicate. The experimental conditions in this pre-experimental phase were identical to those required and described for the mutagenicity assay. The pre-experiment was performed with 10 concentrations of the test item and the solvent and positive controls. All cell cultures were set up in duplicate. Exposure time was 4 hrs (with and without S9 mix) and the cells were prepared 40 hrs after start of the exposure.COMPARISON WITH HISTORICAL CONTROL DATA: yes
Applicant's summary and conclusion
- Conclusions:
- In a valid, reliable and conclusive study according to OECD TG 487 (2010), the test item Reaction mass of CXN1-55 did not induce micronuclei in human lymphocytes in vitro when tested up to the highest required concentration under the experimental conditions. Therefore, Reaction mass of CXN1-55 is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to the highest required concentration.
- Executive summary:
In a valid, reliable and conclusive study according to OECD TG 487 (2010), the test item Reaction mass of CXN1-55, dissolved in deionised water, was assessed for its potential to induce micronuclei in human lymphocytes in vitro in two independent experiments. The following study design was used:
Without S9-Mix With S9-Mix Exp. I Exp. II Exp. I and II Exposure period 4 hrs 20 hrs 4 hrs Recovery 16 hrs - 16 hrs Cytochalasin B exposure 20 hrs 20 hrs 20 hrs Preparation interval 40 hrs 40 hrs 40 hrs Total culture period 88 hrs 88 hrs 88 hrs In each experimental group two parallel cultures were analysed. 1000 binucleate cells per culture were evaluated for cytogenetic damage. No precipitation of the test item in the culture medium was observed.
No relevant cytotoxicity, indicated by reduced CBPI and described as cytostasis, could be observed up to the highest applied concentration either with or without metabolic activation.
The highest applied concentration in Experiment I (5000.0 µg/mL of the test item) was chosen with respect to the current OECD Guideline 487.
In the absence and presence of S9 mix, no relevant increase in the number of micronucleated cells was observed after treatment with the test item. In Experiment I with S9 mix two statistically significant increases (0.90 and 1.20 % micronucleated cells) were observed after treatment with 2857.1 and 5000.0 µg/mL. Since these values are clearly in the range of the historical solvent control data (0.20 – 1.70 % micronucleated cells) the findings are not biologically relevant.
Appropriate mutagens were used as positive controls. They induced statistically significant increases in cells with micronuclei.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)